Influenza Virus Infection Impairs the Gut’s Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids
- 16 August 2021
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 89 (9), e0073420
- https://doi.org/10.1128/iai.00734-20
Abstract
Along with respiratory tract disease per se, viral respiratory infections can also cause extrapulmonary complications with a potentially critical impact on health. In the present study, we used an experimental model of influenza A virus (IAV) infection to investigate the nature and outcome of the associated gut disorders. In IAV-infected mice, the signs of intestinal injury and inflammation, altered gene expression, and compromised intestinal barrier functions peaked on day 7 post-infection. As a likely result of bacterial component translocation, gene expression of inflammatory markers was upregulated in the liver. These changes occurred concomitantly with an alteration of the composition of the gut microbiota and with a decreased production of the fermentative, gut microbiota-derived, products short-chain fatty acids (SCFAs). Gut inflammation and barrier dysfunction during influenza were not attributed to reduced food consumption, which caused in part gut dysbiosis. Treatment of IAV-infected mice with SCFAs was associated with an enhancement of intestinal barrier properties, as assessed by a reduction in translocation of dextran and a decrease in inflammatory gene expression in the liver. Lastly, SCFA supplementation during influenza tended to reduce the translocation of the enteric pathogen Salmonella enterica serovar Typhimurium and to enhance the survival of doubly infected animals. Collectively, influenza infection can remotely impair the gut’s barrier properties and trigger secondary enteric infections. The latter phenomenon can be partially countered by SCFA supplementation.Keywords
Funding Information
- Agence National pour la Recherche (ACROBAT)
This publication has 58 references indexed in Scilit:
- Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid ProductionCell Reports, 2020
- Respiratory Disease following Viral Lung Infection Alters the Murine Gut MicrobiotaFrontiers in Immunology, 2018
- Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosisMicrobiome, 2018
- The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infectionInfluenza and Other Respiratory Viruses, 2017
- Influenza Virus Affects Intestinal Microbiota and Secondary Salmonella Infection in the Gut through Type I InterferonsPLoS Pathogens, 2016
- Influenza A Virus Infection, Innate Immunity, and ChildhoodJAMA Pediatrics, 2015
- Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of DiseaseInfection and Immunity, 2015
- Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell–dependent inflammationThe Journal of Experimental Medicine, 2014
- The co-pathogenesis of influenza viruses with bacteria in the lungNature Reviews Microbiology, 2014
- Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illnessBMC Infectious Diseases, 2010